Cardiovascular Risk Reduction in Patients With Chronic Kidney Disease: Potential for Targeting Inflammation With Canakinumab

[Display omitted]

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2018-05, Vol.71 (21), p.2415-2418
Hauptverfasser:	Cherney, David Z.I., Lytvyn, Yuliya, McCullough, Peter A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Atherosclerosis canakinumab Cardiology Cardiovascular disease Cardiovascular diseases cardiovascular risk Cell adhesion & migration Cholesterol CKD Disease prevention Health risks Heart attacks Heart failure Inflammation Kidney diseases Lipids Low density lipoprotein Monoclonal antibodies Morbidity Mortality Statins Studies Thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!